Gene: SMAD5
Official Full Name: SMAD family member 5provided by HGNC
Gene Summary: The protein encoded by this gene is involved in the transforming growth factor beta signaling pathway that results in an inhibition of the proliferation of hematopoietic progenitor cells. The encoded protein is activated by bone morphogenetic proteins type 1 receptor kinase, and may be involved in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11480 | SMAD5 Knockout cell line (HeLa) | Human | SMAD5 | 1:3~1:6 | Negative | Online Inquiry |
KO11481 | SMAD5 Knockout cell line (HCT 116) | Human | SMAD5 | 1:2~1:4 | Negative | Online Inquiry |
KO11482 | SMAD5 Knockout cell line (HEK293) | Human | SMAD5 | 1:3~1:6 | Negative | Online Inquiry |
KO11483 | SMAD5 Knockout cell line (A549) | Human | SMAD5 | 1:3~1:4 | Negative | Online Inquiry |
SMAD5 Gene Knockout Cell Lines are genetically engineered cell lines where the SMAD5 gene, an essential component of the TGF-beta signaling pathway, has been disrupted through targeted gene knockout techniques. This innovative product facilitates in-depth studies into the functional role of SMAD5 in various biological processes, including cell proliferation, differentiation, and apoptosis, making it an invaluable tool for researchers focused on developmental biology and cancer therapeutics.
The key mechanism by which these knockout cell lines operate is through the deletion or mutation of the SMAD5 gene, leading to an impaired ability to transduce TGF-beta signals. Consequently, researchers can observe the consequent phenotypic changes and pathways that are activated in the absence of this critical signaling molecule. Such insights can elucidate the role of SMAD5 in tumorigenesis and other pathologies, providing a clearer understanding of the complex interplay between cellular signaling and disease progression.
The scientific significance of SMAD5 Gene Knockout Cell Lines extends to numerous research applications, particularly in understanding the implications of dysfunctional TGF-beta signaling in cancer biology and fibrotic diseases. In clinical settings, these cell lines can contribute to the identification of potential therapeutic targets, offering pathways for the development of novel drugs aimed at modulating TGF-beta signaling.
What sets our SMAD5 Gene Knockout Cell Lines apart from alternatives is their high specificity and reproducibility, produced using state-of-the-art CRISPR/Cas9 technology. This precision ensures reliable results while minimizing off-target effects. Furthermore, our product is meticulously validated, affording users confidence in the consistency of experimental outcomes.
Researchers and clinicians will find significant value in utilizing these cell lines, as they provide a streamlined approach to dissecting the biological implications of SMAD5 dysfunction in a controlled environment, ultimately advancing their research objectives. Our commitment to high-quality biological products stems from a robust background in genetic engineering and molecular biology, ensuring that our offerings are at the forefront of research advancements in the field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.